User:RetatrutideRuben
Editor·7,690 edits·since 2024/12
RetatrutideRuben is an editor on PeptidePedia Wiki, editing since 2024 / 12.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
7,690Total edits
28Logged here
22Articles touched
2024/12Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Lixisenatide | 2 | 26 | 8% |
| Dual incretin agonist | 1 | 37 | 3% |
| Semaglutide | 1 | 41 | 2% |
| CagriSema | 1 | 31 | 3% |
| Amylin | 1 | 37 | 3% |
| Custom peptide synthesis | 1 | 28 | 4% |
| ChinaPeptides | 1 | 39 | 3% |
| GLP-1 receptor agonist | 1 | 43 | 2% |
| Liraglutide | 1 | 37 | 3% |
| Trifluoroacetate counterion | 1 | 37 | 3% |
| VendorInvestigate | 1 | 37 | 3% |
| Temperature excursion | 1 | 35 | 3% |
| Bachem Holding (Suzhou) | 1 | 39 | 3% |
| Wuhan Wansheng Biotechnology | 1 | 39 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.